Zoetis (NYSE:ZTS – Free Report) had its target price cut by JPMorgan Chase & Co. from $130.00 to $115.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the stock. A number of other equities research analysts have also commented on the company. Stifel Nicolaus reduced […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | UBS Group Cuts Zoetis (NYSE:ZTS) Price Target to $80.00 | 0 | 10.45 | 10-08-2026 |
| 2 | JFrog (NASDAQ:FROG) Price Target Raised to $115.00 | 0 | 14.6 | 10-08-2026 |
| 3 | Target (NYSE:TGT) Price Target Raised to $157.00 | 0 | 13.85 | 10-08-2026 |
| 4 | TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $72.00 | 0 | 13.04 | 10-08-2026 |
| 5 | Keefe, Bruyette & Woods Cuts Zillow Group (NASDAQ:Z) Price Target to $34.00 | 0 | 12.61 | 10-08-2026 |
| 6 | Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Raised to $146.00 | 0 | 14.22 | 10-08-2026 |
| 7 | Natera (NASDAQ:NTRA) Price Target Raised to $360.00 | 0 | 14.27 | 10-08-2026 |
| 8 | Cabot (NYSE:CBT) Price Target Raised to $78.00 | 0 | 14.69 | 10-08-2026 |
| 9 | Victory Capital (NASDAQ:VCTR) Price Target Raised to $101.00 | 0 | 11.9 | 10-08-2026 |
| 10 | Qiagen (NYSE:QGEN) Price Target Raised to $50.00 | 0 | 14.26 | 10-08-2026 |